- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Quadrivalent Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Quadrivalent Flu Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Quadrivalent Flu Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Intramuscular Injection segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Quadrivalent Flu Vaccine include Sanofi Pasteur, AstraZeneca, CSL, Abbott, and GlaxoSmithKline, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Quadrivalent Flu Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Intramuscular Injection
Nasal Spray
Intradermal Shot
Market segment by Application can be divided into
Hospital
Clinic
Public Health Agency
Other
The key market players for global Quadrivalent Flu Vaccine market are listed below:
Sanofi Pasteur
AstraZeneca
CSL
Abbott
GlaxoSmithKline
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Quadrivalent Flu Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Quadrivalent Flu Vaccine, with price, sales, revenue and global market share of Quadrivalent Flu Vaccine from 2019 to 2022.
Chapter 3, the Quadrivalent Flu Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Quadrivalent Flu Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Quadrivalent Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Quadrivalent Flu Vaccine.
Chapter 13, 14, and 15, to describe Quadrivalent Flu Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Quadrivalent Flu Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Quadrivalent Flu Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Intramuscular Injection
1.2.3 Nasal Spray
1.2.4 Intradermal Shot
1.3 Market Analysis by Application
1.3.1 Overview: Global Quadrivalent Flu Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Public Health Agency
1.3.5 Other
1.4 Global Quadrivalent Flu Vaccine Market Size & Forecast
1.4.1 Global Quadrivalent Flu Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Quadrivalent Flu Vaccine Sales in Volume (2017-2028)
1.4.3 Global Quadrivalent Flu Vaccine Price (2017-2028)
1.5 Global Quadrivalent Flu Vaccine Production Capacity Analysis
1.5.1 Global Quadrivalent Flu Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Quadrivalent Flu Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Quadrivalent Flu Vaccine Market Drivers
1.6.2 Quadrivalent Flu Vaccine Market Restraints
1.6.3 Quadrivalent Flu Vaccine Trends Analysis
2 Manufacturers Profiles
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Quadrivalent Flu Vaccine Product and Services
2.1.4 Sanofi Pasteur Quadrivalent Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Quadrivalent Flu Vaccine Product and Services
2.2.4 AstraZeneca Quadrivalent Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Quadrivalent Flu Vaccine Product and Services
2.3.4 CSL Quadrivalent Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Quadrivalent Flu Vaccine Product and Services
2.4.4 Abbott Quadrivalent Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Quadrivalent Flu Vaccine Product and Services
2.5.4 GlaxoSmithKline Quadrivalent Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Quadrivalent Flu Vaccine Breakdown Data by Manufacturer
3 Quadrivalent Flu Vaccine Breakdown Data by Manufacturer
3.1 Global Quadrivalent Flu Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Quadrivalent Flu Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Quadrivalent Flu Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Quadrivalent Flu Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Quadrivalent Flu Vaccine Manufacturer Market Share in 2021
3.5 Global Quadrivalent Flu Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Quadrivalent Flu Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4 Market Analysis by Region
4.1 Global Quadrivalent Flu Vaccine Market Size by Region
4.1.1 Global Quadrivalent Flu Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Quadrivalent Flu Vaccine Revenue by Region (2017-2028)
4.2 North America Quadrivalent Flu Vaccine Revenue (2017-2028)
4.3 Europe Quadrivalent Flu Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Quadrivalent Flu Vaccine Revenue (2017-2028)
4.5 South America Quadrivalent Flu Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Quadrivalent Flu Vaccine Revenue (2017-2028)
5 Market Segment by Type
5 Market Segment by Type
5.1 Global Quadrivalent Flu Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Quadrivalent Flu Vaccine Revenue by Type (2017-2028)
5.3 Global Quadrivalent Flu Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6 Market Segment by Application
6.1 Global Quadrivalent Flu Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Quadrivalent Flu Vaccine Revenue by Application (2017-2028)
6.3 Global Quadrivalent Flu Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7 North America by Country, by Type, and by Application
7.1 North America Quadrivalent Flu Vaccine Sales by Type (2017-2028)
7.2 North America Quadrivalent Flu Vaccine Sales by Application (2017-2028)
7.3 North America Quadrivalent Flu Vaccine Market Size by Country
7.3.1 North America Quadrivalent Flu Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Quadrivalent Flu Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8 Europe by Country, by Type, and by Application
8.1 Europe Quadrivalent Flu Vaccine Sales by Type (2017-2028)
8.2 Europe Quadrivalent Flu Vaccine Sales by Application (2017-2028)
8.3 Europe Quadrivalent Flu Vaccine Market Size by Country
8.3.1 Europe Quadrivalent Flu Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Quadrivalent Flu Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Quadrivalent Flu Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Quadrivalent Flu Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Quadrivalent Flu Vaccine Market Size by Region
9.3.1 Asia-Pacific Quadrivalent Flu Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Quadrivalent Flu Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10 South America by Region, by Type, and by Application
10.1 South America Quadrivalent Flu Vaccine Sales by Type (2017-2028)
10.2 South America Quadrivalent Flu Vaccine Sales by Application (2017-2028)
10.3 South America Quadrivalent Flu Vaccine Market Size by Country
10.3.1 South America Quadrivalent Flu Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Quadrivalent Flu Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Quadrivalent Flu Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Quadrivalent Flu Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Quadrivalent Flu Vaccine Market Size by Country
11.3.1 Middle East & Africa Quadrivalent Flu Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Quadrivalent Flu Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12 Raw Material and Industry Chain
12.1 Raw Material of Quadrivalent Flu Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Quadrivalent Flu Vaccine
12.3 Quadrivalent Flu Vaccine Production Process
12.4 Quadrivalent Flu Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Quadrivalent Flu Vaccine Typical Distributors
13.3 Quadrivalent Flu Vaccine Typical Customers
14 Research Findings and Conclusion
14 Research Findings and Conclusion
15 Appendix
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Quadrivalent Flu Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Quadrivalent Flu Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur Quadrivalent Flu Vaccine Product and Services
Table 6. Sanofi Pasteur Quadrivalent Flu Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Major Business
Table 9. AstraZeneca Quadrivalent Flu Vaccine Product and Services
Table 10. AstraZeneca Quadrivalent Flu Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. CSL Basic Information, Manufacturing Base and Competitors
Table 12. CSL Major Business
Table 13. CSL Quadrivalent Flu Vaccine Product and Services
Table 14. CSL Quadrivalent Flu Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Abbott Basic Information, Manufacturing Base and Competitors
Table 16. Abbott Major Business
Table 17. Abbott Quadrivalent Flu Vaccine Product and Services
Table 18. Abbott Quadrivalent Flu Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Major Business
Table 21. GlaxoSmithKline Quadrivalent Flu Vaccine Product and Services
Table 22. GlaxoSmithKline Quadrivalent Flu Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Quadrivalent Flu Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)
Table 24. Global Quadrivalent Flu Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Quadrivalent Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Quadrivalent Flu Vaccine Production Capacity by Company, (K Doses): 2020 VS 2021
Table 27. Head Office and Quadrivalent Flu Vaccine Production Site of Key Manufacturer
Table 28. Quadrivalent Flu Vaccine New Entrant and Capacity Expansion Plans
Table 29. Quadrivalent Flu Vaccine Mergers & Acquisitions in the Past Five Years
Table 30. Global Quadrivalent Flu Vaccine Sales by Region (2017-2022) & (K Doses)
Table 31. Global Quadrivalent Flu Vaccine Sales by Region (2023-2028) & (K Doses)
Table 32. Global Quadrivalent Flu Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Quadrivalent Flu Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Quadrivalent Flu Vaccine Sales by Type (2017-2022) & (K Doses)
Table 35. Global Quadrivalent Flu Vaccine Sales by Type (2023-2028) & (K Doses)
Table 36. Global Quadrivalent Flu Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Quadrivalent Flu Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Quadrivalent Flu Vaccine Price by Type (2017-2022) & (USD/Dose)
Table 39. Global Quadrivalent Flu Vaccine Price by Type (2023-2028) & (USD/Dose)
Table 40. Global Quadrivalent Flu Vaccine Sales by Application (2017-2022) & (K Doses)
Table 41. Global Quadrivalent Flu Vaccine Sales by Application (2023-2028) & (K Doses)
Table 42. Global Quadrivalent Flu Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 43. Global Quadrivalent Flu Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 44. Global Quadrivalent Flu Vaccine Price by Application (2017-2022) & (USD/Dose)
Table 45. Global Quadrivalent Flu Vaccine Price by Application (2023-2028) & (USD/Dose)
Table 46. North America Quadrivalent Flu Vaccine Sales by Country (2017-2022) & (K Doses)
Table 47. North America Quadrivalent Flu Vaccine Sales by Country (2023-2028) & (K Doses)
Table 48. North America Quadrivalent Flu Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Quadrivalent Flu Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Quadrivalent Flu Vaccine Sales by Type (2017-2022) & (K Doses)
Table 51. North America Quadrivalent Flu Vaccine Sales by Type (2023-2028) & (K Doses)
Table 52. North America Quadrivalent Flu Vaccine Sales by Application (2017-2022) & (K Doses)
Table 53. North America Quadrivalent Flu Vaccine Sales by Application (2023-2028) & (K Doses)
Table 54. Europe Quadrivalent Flu Vaccine Sales by Country (2017-2022) & (K Doses)
Table 55. Europe Quadrivalent Flu Vaccine Sales by Country (2023-2028) & (K Doses)
Table 56. Europe Quadrivalent Flu Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Quadrivalent Flu Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Quadrivalent Flu Vaccine Sales by Type (2017-2022) & (K Doses)
Table 59. Europe Quadrivalent Flu Vaccine Sales by Type (2023-2028) & (K Doses)
Table 60. Europe Quadrivalent Flu Vaccine Sales by Application (2017-2022) & (K Doses)
Table 61. Europe Quadrivalent Flu Vaccine Sales by Application (2023-2028) & (K Doses)
Table 62. Asia-Pacific Quadrivalent Flu Vaccine Sales by Region (2017-2022) & (K Doses)
Table 63. Asia-Pacific Quadrivalent Flu Vaccine Sales by Region (2023-2028) & (K Doses)
Table 64. Asia-Pacific Quadrivalent Flu Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Quadrivalent Flu Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Quadrivalent Flu Vaccine Sales by Type (2017-2022) & (K Doses)
Table 67. Asia-Pacific Quadrivalent Flu Vaccine Sales by Type (2023-2028) & (K Doses)
Table 68. Asia-Pacific Quadrivalent Flu Vaccine Sales by Application (2017-2022) & (K Doses)
Table 69. Asia-Pacific Quadrivalent Flu Vaccine Sales by Application (2023-2028) & (K Doses)
Table 70. South America Quadrivalent Flu Vaccine Sales by Country (2017-2022) & (K Doses)
Table 71. South America Quadrivalent Flu Vaccine Sales by Country (2023-2028) & (K Doses)
Table 72. South America Quadrivalent Flu Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Quadrivalent Flu Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Quadrivalent Flu Vaccine Sales by Type (2017-2022) & (K Doses)
Table 75. South America Quadrivalent Flu Vaccine Sales by Type (2023-2028) & (K Doses)
Table 76. South America Quadrivalent Flu Vaccine Sales by Application (2017-2022) & (K Doses)
Table 77. South America Quadrivalent Flu Vaccine Sales by Application (2023-2028) & (K Doses)
Table 78. Middle East & Africa Quadrivalent Flu Vaccine Sales by Region (2017-2022) & (K Doses)
Table 79. Middle East & Africa Quadrivalent Flu Vaccine Sales by Region (2023-2028) & (K Doses)
Table 80. Middle East & Africa Quadrivalent Flu Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Quadrivalent Flu Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Quadrivalent Flu Vaccine Sales by Type (2017-2022) & (K Doses)
Table 83. Middle East & Africa Quadrivalent Flu Vaccine Sales by Type (2023-2028) & (K Doses)
Table 84. Middle East & Africa Quadrivalent Flu Vaccine Sales by Application (2017-2022) & (K Doses)
Table 85. Middle East & Africa Quadrivalent Flu Vaccine Sales by Application (2023-2028) & (K Doses)
Table 86. Quadrivalent Flu Vaccine Raw Material
Table 87. Key Manufacturers of Quadrivalent Flu Vaccine Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Quadrivalent Flu Vaccine Typical Distributors
Table 91. Quadrivalent Flu Vaccine Typical Customers
List of Figures
Figure 1. Quadrivalent Flu Vaccine Picture
Figure 2. Global Quadrivalent Flu Vaccine Revenue Market Share by Type in 2021
Figure 3. Intramuscular Injection
Figure 4. Nasal Spray
Figure 5. Intradermal Shot
Figure 6. Global Quadrivalent Flu Vaccine Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Public Health Agency
Figure 10. Other
Figure 11. Global Quadrivalent Flu Vaccine Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028
Figure 12. Global Quadrivalent Flu Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Quadrivalent Flu Vaccine Sales (2017-2028) & (K Doses)
Figure 14. Global Quadrivalent Flu Vaccine Price (2017-2028) & (USD/Dose)
Figure 15. Global Quadrivalent Flu Vaccine Production Capacity (2017-2028) & (K Doses)
Figure 16. Global Quadrivalent Flu Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Quadrivalent Flu Vaccine Market Drivers
Figure 18. Quadrivalent Flu Vaccine Market Restraints
Figure 19. Quadrivalent Flu Vaccine Market Trends
Figure 20. Global Quadrivalent Flu Vaccine Sales Market Share by Manufacturer in 2021
Figure 21. Global Quadrivalent Flu Vaccine Revenue Market Share by Manufacturer in 2021
Figure 22. Quadrivalent Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Quadrivalent Flu Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Quadrivalent Flu Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Quadrivalent Flu Vaccine Sales Market Share by Region (2017-2028)
Figure 26. Global Quadrivalent Flu Vaccine Revenue Market Share by Region (2017-2028)
Figure 27. North America Quadrivalent Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. Europe Quadrivalent Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Quadrivalent Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. South America Quadrivalent Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Quadrivalent Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 32. Global Quadrivalent Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 33. Global Quadrivalent Flu Vaccine Revenue Market Share by Type (2017-2028)
Figure 34. Global Quadrivalent Flu Vaccine Price by Type (2017-2028) & (USD/Dose)
Figure 35. Global Quadrivalent Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 36. Global Quadrivalent Flu Vaccine Revenue Market Share by Application (2017-2028)
Figure 37. Global Quadrivalent Flu Vaccine Price by Application (2017-2028) & (USD/Dose)
Figure 38. North America Quadrivalent Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 39. North America Quadrivalent Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 40. North America Quadrivalent Flu Vaccine Sales Market Share by Country (2017-2028)
Figure 41. North America Quadrivalent Flu Vaccine Revenue Market Share by Country (2017-2028)
Figure 42. United States Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Quadrivalent Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 46. Europe Quadrivalent Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 47. Europe Quadrivalent Flu Vaccine Sales Market Share by Country (2017-2028)
Figure 48. Europe Quadrivalent Flu Vaccine Revenue Market Share by Country (2017-2028)
Figure 49. Germany Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Quadrivalent Flu Vaccine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Quadrivalent Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Quadrivalent Flu Vaccine Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Quadrivalent Flu Vaccine Revenue Market Share by Region (2017-2028)
Figure 58. China Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Quadrivalent Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 65. South America Quadrivalent Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 66. South America Quadrivalent Flu Vaccine Sales Market Share by Country (2017-2028)
Figure 67. South America Quadrivalent Flu Vaccine Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Quadrivalent Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Quadrivalent Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Quadrivalent Flu Vaccine Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Quadrivalent Flu Vaccine Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Quadrivalent Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Quadrivalent Flu Vaccine in 2021
Figure 79. Manufacturing Process Analysis of Quadrivalent Flu Vaccine
Figure 80. Quadrivalent Flu Vaccine Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
